Scientists have created artificial DNA tiles capable of monitoring ion flow across cell membranes and delivering therapeutic payloads without interfering with normal cellular functions. The innovation addresses a longstanding challenge in neuroscience and medicine: measuring the exchange of charged particles that underpins neuron communication and other vital processes.
Living cells rely on ion exchange across their outer membranes for signaling and homeostasis, but existing measurement techniques often damage or alter the cells being studied. The DNA-based tiles offer a non-disruptive alternative, potentially unlocking new insights into brain activity and disease mechanisms.
The tiles are engineered from synthetic DNA strands that self-assemble into nanoscale structures. They can be programmed to bind specific ions or drug molecules, enabling real-time monitoring of ion fluxes or targeted delivery of treatments directly to cell surfaces.
If validated in living systems, the technology could transform drug delivery for neurological conditions and provide researchers with a precise tool for studying neural communication. The approach may also reduce side effects by confining drugs to specific cell types.
Further testing is needed to confirm stability and compatibility with complex biological environments, but the proof-of-concept marks a step toward integrating synthetic DNA with cellular interfaces.